Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 23, 2025
SGS announced the launch of Germany’s first commercial cell sorting service via fluorescent-activated cell sorting (FACS) for the biopharmaceutical industry.
read more
Worldwide Clinical Trials announced Sherilyn Adcock, RPH, PHD, has been promoted to chief scientific officer, Early Phase Development.
read more
Paragon Bioservices has announced two key leadership promotions.
read more
Colorcon has announced its investment to build a new starch manufacturing plant close to Amsterdam in The Netherlands.
read more
Wednesday, March 12, 2014
Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) Southeast conference, which is being held in Rho’s backyard...
read more
Monday, November 20, 2017
Quanticate has launched its centralized statistical monitoring service as an extension of its statistical consultancy offering.
read more
4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, entered an agreement to receive a growth equity investment of over $230M from Goldman Sachs. The investment will be used to fund 4G Clinical's continued global ...
read more
Tuesday, November 19, 2024
Ardena announced the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, Netherlands.
read more
Friday, September 20, 2019
The FDA has classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized.
read more
RedHill Biopharma has entered into a binding term sheet with Cosmo Pharmaceuticals for an exclusive licensing and manufacturing agreement for multiple products.
read more
Monday, September 25, 2023
Mikart announced its recent acquisition of the state-of-the-art Flexpack NF-150 Horizontal Sachet-Packaging Machine. This strategic investment marks a significant milestone in Mikart's, commitment to enhancing its production capabilities and ...
read more
Tuesday, November 28, 2023
Charles River Laboratories International, Inc. and Genetic Cures for Kids Inc (GC4K) have jointly revealed a groundbreaking collaboration in plasmid DNA contract development and manufacturing organization (CDMO).
read more
The FDA is rolling out a series of reforms intended to accelerate and modernize clinical research across the full continuum of drug development, from pre IND interactions through late stage pivotal trials.
read more
Wednesday, September 16, 2015
The FDA is making changes to the requirements for monitoring, prescribing, dispensing, and receiving the schizophrenia medicine clozapine, to address continuing safety concerns and current knowledge about a serious blood condition called severe ...
read more
Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system (CNS), and rare disease, has entered into an agreement to partner with N-SIDE — a deeptech ...
read more